STRATUMfiling intelligence๐Ÿ‡ฎ๐Ÿ‡ณ Indian private portal

CIK 1537561

ARCH THERAPEUTICS, INC.
CIK 0001537561 ยท EDGAR โ†—
cleanelevatedtriggeredno dataplanned
93.9
composite ยท 3 signals ยท TRIGGERED

Every card below shows the score and the exact filing data it was computed from โ€” no unexplained numbers. Some signals (P-02, P-03, P-08, P-09, P-10, P-11) pull live documents from SEC EDGAR the first time you view this company; a few of those (P-03, P-10, P-11) use AI to read the filing text, but every AI claim must quote the actual document verbatim or it's discarded โ€” never a guess.

Chat with this filing โ†’

Ask follow-up questions about the latest 10-K, with citations verified against the actual text. No account needed.

Investigation memo โ€” generate one โ†’

Run the bounded investigation agent โ€” reads this company's signals and writes a short, cited summary.

Signals

P-01 ยท FY 2023-09-30 ยท TRIGGERED100.0

Earnings quality

Beneish M-Score 28.80 exceeds the -1.78 manipulation threshold
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2024-02-15) โ†—
Evidence โ€” inputs and thresholds
{
  "m_score": 28.804,
  "threshold": -1.78,
  "ratios": {
    "DSRI": 1,
    "GMI": 71.086,
    "AQI": 1.33,
    "SGI": 4.838,
    "DEPI": 2.037,
    "SGAI": 0.2,
    "LVGI": 3.791,
    "TATA": -1.843
  },
  "defaulted_to_neutral": [
    "DSRI"
  ],
  "sloan_accruals": -1.5821,
  "inputs": {
    "revenue_t": 75724,
    "revenue_t1": 15652,
    "total_assets_t": 1958189,
    "net_income_t": -6982836,
    "cfo_t": -3374216
  },
  "stale": false,
  "latest_filing_period": "2023-09-30",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1537561/000143774924004234/0001437749-24-004234-index.htm",
    "form": "10-K",
    "filed": "2024-02-15"
  }
}
P-13 ยท FY 2023-09-30 ยท TRIGGERED100.0

Zombie / distress

Zombie: interest coverage below 1.0x for 4 consecutive years
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2024-02-15) โ†—
Evidence โ€” inputs and thresholds
{
  "icr_by_year": {
    "2023-09-30": -1.629,
    "2022-09-30": -10.068,
    "2021-09-30": -42.364,
    "2020-09-30": -288.773
  },
  "consecutive_years_below_1": 4,
  "altman_z_double_prime": -146.633,
  "definitions": {
    "zombie": "ICR<1 for 3+ consecutive FYs (BIS 2018)",
    "z_distress": "<1.1 distress, 1.1-2.6 gray, >2.6 safe"
  },
  "inputs": {
    "ebit_t": -5044483,
    "interest_expense_t": 3096550
  },
  "stale": false,
  "latest_filing_period": "2023-09-30",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1537561/000143774924004234/0001437749-24-004234-index.htm",
    "form": "10-K",
    "filed": "2024-02-15"
  }
}
P-12 ยท FY 2023-09-30 ยท ELEVATED54.4

Restatement predictor

F-Score 1.63 โ€” misstatement risk 1.6x the base rate
trend: flat
Trend
Source: 10-K on SEC.gov (filed 2024-02-15) โ†—
Evidence โ€” inputs and thresholds
{
  "f_score": 1.632,
  "probability": 0.00604,
  "components": {
    "rsst": -1.5821,
    "drec": null,
    "dinv": -0.0221,
    "soft": 0.9977,
    "dcs": 3.838,
    "droa": -1.5397,
    "issue": 0
  },
  "model": "Dechow et al. 2011, Model 1 (simplified RSST)",
  "thresholds": {
    "elevated": 1,
    "triggered": 1.85
  },
  "stale": false,
  "latest_filing_period": "2023-09-30",
  "source": {
    "url": "https://www.sec.gov/Archives/edgar/data/1537561/000143774924004234/0001437749-24-004234-index.htm",
    "form": "10-K",
    "filed": "2024-02-15"
  }
}